| Pancreatic Cancer (Carcinoma of the Pancreas) |
 |
|
What
is cancer?
In theory, cancer can occur in any organ of the human body. Individual
cells begin to reproduce in greater numbers than normal, the surrounding
tissue cannot control their growth and these cells escape and establish
themselves in other tissue or organs. Cancer commonly occurs as a result
of congenital or acquired genetic defects. It is still not known in
many cases what causes these defects. Untreated cancer will grow out
of control and destroy the functions of the organ. It will also invade
other organs nearby. Of greatest danger is the fact that cancer cells
can be transported to other organs via bloodstream and lymphatic system
(i.e. formation of metastases).
The goal of any surgical treatment is the complete
removal of the cancer. Doctors use the term 'curative surgery'. If surgery
is performed primarily to relieve symptoms (e.g. to reduce pain or to
remove blocked passages), the term 'palliative surgery' is used. Cancer
cells may remain in the body even if curative surgery is performed,
as some cancerous cells may have spread (or "metastasised") to surrounding
tissue or other organs undetected. These cells often remain concealed
during surgery. If doctors suspect that cancerous cells have escaped
detection, chemotherapy or radiotherapy is recommended. This will usually
suppress any such cells. This is known as 'adjuvant therapy'.
If a tumour cannot be completely removed, chemotherapy
or radiotherapy may also be recommended to slow malignant growth or
to reduce the symptoms caused by remnants of the tumour. Serious side
effects, such as nausea, vomiting and hair-loss, once quite common,
are now much more infrequent. This was achieved by breakthroughs in
chemotherapy and radiotherapy.
Clinical research must be conducted to achieve further
advancement in cancer treatment. Patients are separated into groups
according to form of treatment (i.e. traditional vs. experimental treatment).
Thus results can be evaluated as to their success. The best care for
the patient will always have the highest priority.
|
| |
|
|
|
Picture of the main duct of the pancreas
with different forms of cancer.
(ERCP picture) |
|
| |
|
What
is pancreatic cancer?
This malignant tumour usually develops in the ducts of the pancreas
head. Its growth will usually lead to a malfunctioning of the pancreas
or to a blocking of the bile flow in the liver. Gradually the tumour
will affect the surrounding blood vessels, nerves and lymph nodes. When
reaching this phase, cancerous cells will migrate and metastases will
be found in other organs. The cancer has reached a generalised state
that cannot be removed locally.
Cancerous growth depends on many factors. Some cells
are very aggressive and fast growing, some have clearly identifiable
characteristics and grow much more slowly. The patient's age, general
health and immune system (which can be damaged by smoking and excessive
drinking) play an important role. Usually pancreas cancer patients are
60 and over, however in rare cases younger people can be affected.
A tumour in the head of the pancreas can also block
the main pancreatic duct, preventing the digestive enzymes which are
normally produced in the pancreas from reaching the intestines. This
leads to poor digestion, weight loss and diarrhoea. These symptoms can
be relieved by taking pancreatic enzyme supplements in tablet form,
or by clearing the obstruction in the main pancreatic duct. Often the
symptoms of diabetes mellitus appear before pancreatic cancer is diagnosed.
Diabetes mellitus can however appear both after the diagnosis of cancer
and after a pancreas operation. The most common form of pancreatic cancer
arises in the duct cells in the head of the pancreas. Most patients
are over the age of 60, but younger people may also develop the disease.
The disease takes a similar course if the cancer does
not originate in pancreatic tissue, but in the deep-seated bile duct
(which also traverses the pancreas head), or in the papilla (draining
channel for pancreatic fluid and bile leading into the duodenum). These
cancer forms have one redeeming factor: they can be detected early through
icterus (typical eye discoloration indicating the presence of jaundice).
Finally we need to mention the cystic forms of pancreatic cancer. They
are not easily differentiated from benign tumours or pseudo cysts, which
can be observed with chronic pancreatitis patients. Considerable experience
before and after surgery is required to determine the appropriate therapy.
|
| |
|
How
does pancreatic cancer develop?
In recent years, fundamental research using methods based on molecular
biology has lead to a significant extension to our knowledge about the
genesis of pancreatic cancer.
Scientists have increasingly observed the presence
of growth stimulating factors (growth factors), as well as alterations
(mutations) of certain hereditary genes. These would control cell growth
and cell death (apoptosis) under normal circumstances. However, when
mutation occurs, pancreatic cancer cells tend to grow more rapidly than
healthy tissue. These changes are probably responsible for the resistance
of the tumour to chemotherapy and radiotherapy. Further research into
pancreatic cancer is necessary to pinpoint the exact character of those
changes that could serve as basis for the development of new therapies.
This research will develop improved methods to combat pancreatic cancer.
|
 |
|
What
are the symptoms?
Pancreatic cancer unfortunately has no characteristic symptoms in its
early stages. Most often, deterioration in general well-being is observed
and the patient will suffer from loss of appetite and weight.
Often patients complain about unusual pains in the
upper abdomen, these can sometimes spread to the back; and gradually
increase in intensity as the disease advances. Tumours located in the
pancreas head can disrupt bile flow. This leads to jaundice, which can
be accompanied by colourless stool, dark urine and itchy skin. Absence
of pain and fever with this type of jaundice must be interpreted as
a clear danger signal. Diabetes mellitus developing for the first time
is another common sign of pancreatic cancer.
|
 |
|
What
are the causes?
The exact causes of pancreatic cancer remain unknown at this time. The
only known risk factor is smoking. Excessive coffee consumption and/or
a penchant for fatty meals have not been established as causes of pancreatic
cancer. Whether increased alcohol consumption leads to a higher risk
for developing the disease is also an open question. It has however
been established that genetic predispositions exist, as the disease
is more frequent in some families.
|
 |
|
How
can pancreatic cancer be detected at any early stage?
Regrettably it is often impossible to detect pancreatic cancer in its
early stages at this time. Basic medical procedures for early detection
do not exist. However, intensive research is being carried out to improve
the chances of early detection, and this will certainly lead to new
and improved diagnostic procedures in clinical practice.
|
| |
|
What
treatments exist for pancreatic cancer?
Surgery, (removal of the tumour) is the only procedure that can bring
about a cure. Surgery can only be carried out if cancer cells have not
spread to other organs, such as the liver, the lungs or the surrounding
vessels, in which case it is impossible to remove it outright. Experience
shows that only 25% of all patients with pancreatic cancer can be treated
with surgery. Besides the actual tumour, the adjoining healthy part
of the pancreas needs to be removed as well. Other organs or parts thereof
will be removed if the position of the tumour makes this necessary.
At an advanced stage of the disease, complete
removal of the tumour is often impossible. Therapy will then aim to
relieve the patient's symptoms. The flow of bile must be restored if
the bile duct is blocked and the patient is suffering from jaundice.
This can be done endoscopically by inserting a tube into the bile duct,
or by a surgical procedure, known as biliodigestive anastomosis, during
which a piece of the intestine is sewn on to the bile duct, to ensure
the flow of bile.
If the tumour grows into the duodenum, it will obstruct
the passage of food, i.e. food cannot pass easily or not at all from
the stomach into the intestine. To bypass this predicament, surgery
known as gastroenterostomy, will be performed (this procedure joins
the stomach to the small intestine).
The benefits of radiotherapy and/or chemotherapy in
the treatment of pancreatic cancer have not been convincing. Efforts
are being made to develop new and more effective forms of treatment
for pancreatic cancer. A range of new procedures is undergoing clinical
tests at present.
|
 |
|
What
are the permanent consequences of pancreatic cancer and what form of
after-care is given?
Many patients suffer from diabetes mellitus before pancreatic cancer
is diagnosed. The condition will usually stabilise after surgery, sometimes
however it can improve or deteriorate. In most cases insulin therapy
is required.
The removal of a part of the pancreas will lead
to a reduced production of digestive enzymes, which in turn will cause
weight loss, bloating or diarrhoea. This condition can be treated quite
easily with medication containing pancreatic enzymes.
After surgery, patients must be regularly monitored
by medical checks, lab tests and medical imaging (ultrasound, CAT, MRT).
Problems arising from surgery can thus be corrected and resurging tumours
can be detected early. Further therapy can be applied if necessary.
These tests are conducted in consultation with the
GP. Often, additional therapy, e.g. chemotherapy, can be carried out
as part of clinical studies and organised on a case-by-case basis with
patient, surgeon, oncologist (cancer specialist) and family doctor.
|
 |
|
What
are the chances for a cure?
In recent years, pancreas surgery has become
a very safe procedure. Nevertheless, very few patients survive the first
5 years after the operation, as surgery would have been performed too
late. In cases where the tumour cannot be removed, patients seldom survive
for more than two years. The amount of research being carried out gives
rise to hope that this situation will improve significantly in years
to come.
Genetic therapies are of special interest for pancreatic
cancer research. Knowledge of the complex factors that cause pancreatic
cancer has improved considerably in recent years.
This knowledge, combined with genetic therapies can
raise hopes for a new start.
A realistic assessment of the situation shows however
that actual therapies have not materialised at this time. Additional
studies have lead to a better understanding of changes observed in the
molecular-biological structure of pancreatic cancer and have thus established
the basis of a new approach to genetic therapies. However, early surgery
is still the most promising therapy at this time.
|
 |
|
Part
of my pancreas has been removed - what happens now?
Patients who have had a part or the whole of
their pancreas removed may experience a reduction in the functioning
of their pancreas, dependent on how much of the organ has been lost.
This leads to two problems, above all:
- Too few pancreatic enzymes (leading to digestion problems)
- Too little insulin (leading to high blood-sugar levels)
These deficiencies can be rectified by taking suitable medication.
1. Pancreatic Enzyme Substitution
Nowadays there are excellent, modern preparations on the market which
contain substances that replace the pancreatic enzymes (e.g. Creon,
Fig. 7). These preparations must be taken with all meals, including
fat- or protein-rich snacks. The required dosage varies from patient
to patient and is determined by the nature of the food and the symptoms
of the patient. It is essential that the therapy eliminates the patient's
bloated feeling and the foul-smelling diarrhoea with the fatty deposits.
Typically, 2-3 capsules have to be taken with main meals and 1-2 capsules
with snacks. It is important that the pancreatic enzymes reach the food
so that they can fulfil their function. For this to happen, from 6-12
capsules need to be taken every day. These numbers may be significantly
higher or lower, dependent on how well the remaining part of the pancreas
functions.
These enzyme preparations are normally easily
digestible and have virtually no side-effects. In very rare cases, they
can cause an allergic reaction.
2. Insulin Substitution
If the pancreatic disorder or operation lead to high blood sugar
levels being recorded, the patient will require an appropriate form
of blood sugar therapy. To start with, and where the blood sugar levels
are not particularly high, the situation can be controlled by following
a suitable diet and taking tablets which influence the sugar level.
However, where extensive resectioning of the pancreas has been carried
out, direct insulin replacement treatment is sometimes required. Various
forms of insulin are now available for this treatment. These either
come from animals or are manufactured using gene technology. For the
most part, these are identical to human insulin and are therefore described
as human insulin. All forms of insulin must be injected. The large variety
of insulin types allow the therapy to be tailored to the needs of the
patient and special attention can be paid to eating habits. The aim
of any therapy is to ensure that the patient feels well and the blood
sugar levels are kept under control. By doing this, serious damage to
the health can be avoided, both in the short and the long term. It is
particularly important in the initial phase of treatment that the patient
is closely monitored by his family doctor or specialists in the field.
|
 |
|
My
spleen has been removed - what happens now?
Sometimes the spleen is also removed as part
of an operation on the pancreas.
It is quite possible to live without a spleen.
The spleen plays a certain role in the human immune system. If it is
removed, a person is more susceptible to bacterial infections. To provide
protection against infection after removal of the spleen, the patient
should be given certain inoculations after the operation. According
to current guidelines, these inoculations should be repeated every 3
to 5 years. In addition, the patient should always seek medical help
if he contracts a serious infection, and tell the doctor that he or
she no longer has a spleen. The doctor can then decide whether treatment
with antibiotics is required.
The removal of the spleen can also lead to a build-up
of blood platelets (thrombocytes). It is important to have this situation
regularly monitored. If the number of platelets is too high, this can
lead to the thickening of the blood and a possible thrombosis. If the
level is too high, your doctor will prescribe a temporary course of
medication to thin the blood, in order to reduce the risk of thrombosis.
|
| |
| |